Fresenius moves forward with two U.S. expansions after killing Akorn deal
admin 10th April 2019 Uncategorised 0Fresenius Kabi missed an opportunity to quickly bulk up in sterile manufacturing when its $5 billion deal to buy Akorn imploded last year, but its organic expansion efforts in the U.S. are moving forward. More: Fresenius moves forward with two
read more